Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients

Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients - Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014860

Enrollment

Registered

2014-09-01

Start date

2014-10-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial cystitis

Interventions

intravesical administration of DMSO

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: interstitial cystitis

Exclusion criteria

Exclusion criteria: r/o interstitial patients

Design outcomes

Primary

Measure	Time frame
rate of inprovement in questionnaire	—

Secondary

Measure	Time frame
urinary frequency voided volume per micturition safety	—

Countries

Japan

Contacts

Public ContactTakeya KItta

Hokkaido University Graduate School of Medicine Urology

kitta@fb3.so-net.ne.jp011-706-5966

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026